yemenjmedYemen Journal of MedicinecoVolume 1 Issue 2MultidisciplinaryEnglishJuly - December 2022NNY20250329ArticleA case of acute ischemic stroke in moyamoya syndrome associated with Graves’ disease: Is there a role for anti-dsDNA antibodies?EnglishY9396SumairaRafiqueEnglishNKoutaiba RidaObaidEnglishYIslam AhmedHassanEnglishY10.32677/yjm.v1i2.3386The coexistence of Moyamoya syndrome (MMS) and Graves’ disease (GD) is uncommon. Here, we report a case of a 41-year-old Filipino female, who presented with thyrotoxicosis and acute ischemic stroke. Based on her clinical presentation, cerebral computed tomography angiography, and thyroid function tests, she was diagnosed with MMS and GD. Her Burch-Wartofsky point scale score was 30, suggesting an impending thyroid storm. Antithyroid therapy was started with her neurological status deterioration initially, but after controlling the thyroid storm, the patient’s neurological status stabilized. She remained stable till she travelled to her country. We hypothesized that MMS in a patient with GD is mediated through anti-dsDNA antibodies, by altering key biological mechanisms, that is, inflammation, neutrophil extracellular traps, and apoptosis that drive a distinctive and coordinated immune and vascular activation. To the best of our knowledge, this is the first case of MMS associated with GD reported in Qatar.EnglishAcute stroke, Graves’ disease, Moyamoya disease, Moyamoya syndrome, Thyrotoxicosishttps://www.yemenjmed.com/admin/abstract?id=32References16191. Demartini Z Jr., Teixeira BC, Koppe GL, et al. Moyamoya disease and syndrome: A review. Radiol Bras 2022;55:31-7.2. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226-37.3. Ginsberg J. Diagnosis and management of Gravesand;rsquo; disease. CMAJ 2003;168:575-85.4. Khandelwal P, Shah N, Prakash T, et al. Familial presentation of intracranial occlusive arteriopathy and ischemic stroke in patients with Gravesand;rsquo; hyperthyroidism. US Endocrinol 2015;11:89-91.5. Kushima K, Satoh Y, Ban Y, et al. Gravesand;rsquo; thyrotoxicosis and moyamoya disease. Can J Neurol Sci 1991;18:140-2.6. See TT, Lee SP, Tang CW. Moyamoya disease and thyrotoxic painless thyroiditis: A case report. J Intern Med Taiwan 2014;25:20-4.7. Shen AL, Ryu SJ, Lin SK. Concurrent moyamoya disease and Gravesand;rsquo; thyrotoxicosis: Case report and literature review. Acta Neurol Taiwan 2006;15:114-9.8. Ni J, Zhou LX, Wei YP, et al. Moyamoya syndrome associated with Gravesand;rsquo; disease: A case series study. Ann Transl Med 2014;2:77.9. Cheon CK, Kim SY, Yoo JH. Two adolescent patients with coexistent Gravesand;rsquo; disease and Moyamoya disease in Korea. Korean J Pediatr 2014;57:287-91.10. Nakamura H, Sato K, Yoshimura S, et al. Moyamoya disease associated with Gravesand;rsquo; disease and down syndrome: A case report and literature review. J Stroke Cerebrovasc Dis 2021;30:105414.11. Li D, Yang W, Xian P, et al. Coexistence of moyamoya and Gravesand;rsquo; diseases: The clinical characteristics and treatment effects of 21 Chinese patients. Clin Neurol Neurosurg 2013;115:1647-52.12. Suzuki S, Mitsuyama T, Horiba A, et al. Moyamoya disease complicated by Gravesand;rsquo; disease and Type 2 diabetes mellitus: Report of two cases. Clin Neurol Neurosurg 2011;113:325-9.13. Malik S, Russman AN, Katramados AM, et al. Moyamoya syndrome associated with Gravesand;rsquo; disease: A case report and review of the literature. J Stroke Cerebrovasc Dis 2011;20:528-36.14. Ishigami A, Toyoda K, Suzuki R, et al. Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome. J Stroke Cerebrovasc Dis 2014;23:1256-8.15. Ohba S, Nakagawa T, Murakami H. Concurrent Gravesand;rsquo; disease andand;nbsp;intracranial arterial stenosis/occlusion: Special considerations regarding the state of thyroid function, etiology, and treatment. Neurosurg Rev 2011;34:297-304.16. Ito H, Yokoi S, Yokoyama K, et al. Progressive stenosis and radiological findings of vasculitis over the entire internal carotid artery in moyamoya vasculopathy associated with Gravesand;rsquo; disease: A case report and review of the literature. BMC Neurol 2019;19:34.17. Hsu SW, Chaloupka JC, Fattal D. Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis. AJNR Am J Neuroradiol 2006;27:643-7.18. Li H, Zhang ZS, Dong ZN, et al. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: A casecontrol study. Stroke 2011;42:1138-9.19. Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: A prospective study. Stroke 2010;41:173-6.20. Liu JS, Juo SH, Chen WH, et al. A case of Gravesand;rsquo; diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc 1994;93:806-9.21. Garcin B, Louissaint T, Hosseini H, et al. Reversible chorea in association with Gravesand;rsquo; disease and moyamoya syndrome. Mov Disord 2008;23:620-2.22. Tokimura H, Tajitsu K, Takashima H, et al. Familial moyamoya disease associated with Gravesand;rsquo; disease in a mother and daughter. Two case reports. Neurol Med Chir (Tokyo) 2010;50:668-74.23. Pedro AB, Romaldini JH, Americo C, et al. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Gravesand;rsquo; disease and Hashimotoand;rsquo;s thyroiditis patients. Exp Clin Endocrinol Diabetes 2006;114:35-8.24. Patiand;ntilde;o-Trives AM, Pand;eacute;rez-Sand;aacute;nchez C, Pand;eacute;rez-Sand;aacute;nchez L, et al. Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation. Arterioscler Thromb Vasc Biol 2021;41:2417-30.25. Endo H, Fujimura M, Niizuma K, et al. Efficacy of revascularization surgery for moyamoya syndrome associated with Gravesand;rsquo; disease. Neurol Med Chir (Tokyo) 2010;50:977-83.